Wird geladen...
Stroke Prevention in Atrial Fibrillation – The Use of NOACs in Everyday Clinical Practice
Non-antivitamin K oral anticoagulants (NOACs) have recently emerged as a new class of antithrombotic drugs. Four large-scale, randomised controlled trials (RCT) accredited dabigatran, rivaroxaban and edoxaban with evident advantages for stroke prevention in atrial fibrillation (AF) compared with war...
Gespeichert in:
| Veröffentlicht in: | Eur Cardiol |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Radcliffe Cardiology
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6159476/ https://ncbi.nlm.nih.gov/pubmed/30310429 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/ecr.2015.10.2.76 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|